KRYS — Krystal Biotech Share News
0.000.00%
Last trade - 00:00- $9.77bn
- $8.92bn
- $389.13m
Krystal Biotech falls as Q1 revenue misses estimates
Brief: Krystal Biotech Q1 Net Income USD 932 Thousand
Krystal Biotech Inc expected to post earnings of 15 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Agiliti, Domino's Pizza, Krystal Biotech
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
Krystal Biotech Inc reports results for the quarter ended in December - Earnings Summary
Krystal Biotech rises on upbeat Q4 results
Brief: Krystal Biotech Q4 Net Income USD 8.692 Million
Krystal Biotech Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: Krystal Bio Receives FDA Fast Track Designation For Inhaled Oncology Candidate KB707
Brief: Krystal Biotech Receives Permanent J-Code (J3401) For VYJUVEK
Some US gene therapy developers set to end 2023 on a high
Brief: Krystal Biotech Receives Orphan Drug Designation from the Japanese MHLW for Beremagene Geperpavec-svdt
Brief: Krystal Biotech Announces EMA Validation Of Marketing Authorization Application For VYJUVEK
Stifel says Krystal needs robust start form growth; shares fall
Brief: Krystal Biotech Announces Third Quarter 2023 Financial Results And Provides Business Update
Brief: Krystal Biotech Q3 Net Income USD 80.747 Million
Krystal Biotech Inc expected to post a loss of 29 cents a share - Earnings Preview